Completion node dissection in patients with sentinel node-positive melanoma of the head and neck

Otolaryngology - Head and Neck Surgery (United States)

Volumn 146, Issue 4, 2012, Pages 591-599

  Smith, Valerie A ^a   Cunningham, Joan E ^a   Lentsch, Eric J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

completion lymphadenectomy; head and neck cancer; melanoma; sentinel lymph node biopsy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CUTANEOUS MELANOMA; DISEASE SPECIFIC SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; AGE; CANCER STAGING; CHI SQUARE DISTRIBUTION; HEAD AND NECK TUMOR; LYMPHADENECTOMY; MELANOMA; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODE EXCISION; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 84861666134     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599811432672     Document Type: Article

References (21)

1. The National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Melanoma. Version 4.2011. http://www.nccn.org/professionals/ physician-gls/f-guidelines.asp
2. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008 ; 26: 4296-4303
3. Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG. Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy. Ann Surg Oncol. 2010 ; 17: 514-520
4. Wong SL, Morton DL, Thompson JF, et al. Melanoma patients with positive sentinel lymph nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol. 2006 ; 13: 809-816
5. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000 ; 7: 87-97
6. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 2003 ; 10: 21-26
7. Lentsch EJ, McMasters KM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther. 2003 ; 3: 673-683
8. Gomez-Rivera F, Santillan A, McMurphy AB, et al. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck. 2008 ; 30: 1284-1294
9. National Cancer Institute. SEER Brochure. NIH Publication No. 05-4772. September2005. http://www.seer.cancer.gov/about/SEER-brochure.pdf
10. AJCC Cancer Staging Manual. 7 th ed.New York: Springer; 2010. New York: Springer ; 2010 :
11. Quaglino P, Ribero S, Osella-Abate S, et al. Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: a single centre observation cohort study. Surg Oncol. 2011 ; 20: 259-264
12. Sabel MS, Griffith K, Sondak VK, et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg. 2005 ; 201: 37-47
13. Morton DL, Wen DR, Wong JH, et al. Technical details of intra-operative lymphatic mapping for early stage melanoma. Arch Surg. 1992 ; 127: 392-399
14. McMasters KM, Reintgen D, Ross MI, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol. 2001 ; 19: 2851-2855
15. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999 ; 17: 976-983
16. Fincher TR, McCarty TM, Fisher TL, et al. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg. 2003 ; 186: 675-681
17. Chao C, Wong SL, Ross MI, et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg. 2002 ; 184: 520-524
18. Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol. 2007 ; 14: 1934-1942
19. Pidhorecky I, Lee RJ, Proulx G, et al. Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol. 2001 ; 8: 109-115
20. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996 ; 224: 255-266
21. Ariyan C, Brady MS, Gonen M, Busam K, Coit D. Positive nonsentinel nodestatus predicts mortality in patients with cutaneous melanoma. Ann Surg Oncol. 2009 ; 16: 186-190